Bifogade filer
Kurs
-1,10%
Likviditet
0,23 MNOK
Kalender
Tid* | ||
2024-11-06 | - | X-dag bonusutdelning VISTN 0.5 |
2024-11-06 | - | X-dag halvårsutdelning VISTN 0.5 |
2024-10-31 | - | Kvartalsrapport 2024-Q3 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-06-05 | - | X-dag bonusutdelning VISTN 0.5 |
2024-06-05 | - | X-dag halvårsutdelning VISTN 0.5 |
2024-05-23 | - | Årsstämma |
2024-04-24 | - | Kvartalsrapport 2024-Q1 |
2024-02-16 | - | Bokslutskommuniké 2023 |
2024-01-23 | - | X-dag ordinarie utdelning VISTN 0.75 NOK |
2024-01-23 | - | X-dag bonusutdelning VISTN 0.75 |
2023-10-25 | - | Kvartalsrapport 2023-Q3 |
2023-08-23 | - | Kvartalsrapport 2023-Q2 |
2023-05-23 | - | X-dag ordinarie utdelning VISTN 0.00 NOK |
2023-05-22 | - | Årsstämma |
2023-04-27 | - | Kvartalsrapport 2023-Q1 |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-10-26 | - | Kvartalsrapport 2022-Q3 |
2022-08-19 | - | Kvartalsrapport 2022-Q2 |
2022-05-24 | - | X-dag ordinarie utdelning VISTN 0.00 NOK |
2022-05-19 | - | Årsstämma |
2022-04-27 | - | Kvartalsrapport 2022-Q1 |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-10-28 | - | Kvartalsrapport 2021-Q3 |
2021-08-19 | - | Kvartalsrapport 2021-Q2 |
2021-05-21 | - | X-dag ordinarie utdelning VISTN 0.50 NOK |
2021-05-21 | - | X-dag bonusutdelning VISTN 0.5 |
2021-05-20 | - | Årsstämma |
2021-04-23 | - | Kvartalsrapport 2021-Q1 |
2021-02-19 | - | Bokslutskommuniké 2020 |
2020-10-30 | - | Kvartalsrapport 2020-Q3 |
2020-08-28 | - | Kvartalsrapport 2020-Q2 |
2020-06-24 | - | Extra Bolagsstämma 2020 |
2020-05-20 | - | X-dag ordinarie utdelning VISTN 1.00 NOK |
2020-05-19 | - | Årsstämma |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-02-28 | - | Bokslutskommuniké 2019 |
2019-10-25 | - | Kvartalsrapport 2019-Q3 |
2019-08-29 | - | Kvartalsrapport 2019-Q2 |
2019-05-23 | - | X-dag ordinarie utdelning VISTN 0.00 NOK |
2019-05-22 | - | Årsstämma |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-02-19 | - | Bokslutskommuniké 2018 |
2018-10-25 | - | Kvartalsrapport 2018-Q3 |
2018-08-30 | - | Kvartalsrapport 2018-Q2 |
2018-05-25 | - | X-dag ordinarie utdelning VISTN 1.00 NOK |
2018-05-08 | - | Årsstämma |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-02-27 | - | Bokslutskommuniké 2017 |
2017-11-03 | - | X-dag bonusutdelning VISTN 7 |
2017-11-02 | - | Extra Bolagsstämma 2017 |
2017-10-27 | - | Kvartalsrapport 2017-Q3 |
2017-08-31 | - | Kvartalsrapport 2017-Q2 |
2017-05-26 | - | X-dag ordinarie utdelning VISTN 1.00 NOK |
2017-05-24 | - | Årsstämma |
2017-04-26 | - | Kvartalsrapport 2017-Q1 |
2017-02-28 | - | Bokslutskommuniké 2016 |
2016-10-31 | - | Kvartalsrapport 2016-Q3 |
2016-08-30 | - | Kvartalsrapport 2016-Q2 |
2016-05-25 | - | X-dag ordinarie utdelning VISTN 0.60 NOK |
2016-05-24 | - | Årsstämma |
2016-04-28 | - | Kvartalsrapport 2016-Q1 |
2016-02-23 | - | Bokslutskommuniké 2015 |
2015-10-29 | - | Kvartalsrapport 2015-Q3 |
2015-08-26 | - | Kvartalsrapport 2015-Q2 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Oslo, Norway, 28 April 2020
Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 19 May at 10:00 CEST.
A physical Annual General Meeting will not be held. Instead, shareholders should authorize the Chairman of the Board. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of proxy, see general information at the bottom of the notice and enclosed proxy forms.
The recommendation from the Election Committee, remuneration policy, remuneration report for 2021 and the 2021 annual report is also attached to this announcement and available on the Company's website. The formal call will be sent to all shareholders registered in the Norwegian Central Security Depository (VPS) and are also attached to this announcement.
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
alexander.karlsen@vistin.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachments
2022 04 01 Proposal Election committee Vistin ASA signed
21_Independent_auditor-s_assurance_report_on_remuneration_report
Annual Report 2021 for Vistin Pharma ASA
Call for annual general meeting 19 May 2022
Remuneration policy for salary and other remuration for executive management and board members
Remuration report for salary and other remuration for executive management and board members